Abstract:Daidzein is a water-insoluble phytoestrogenic isoflavone of the Leguminosae family, mainly found in soy and soy-derived foods. Daidzein has a broad spectrum of physiological and pharmacological functions. It has anti-cancer, anti-inflammatory, antioxidant, enzyme inhibitor properties and causes a decrease in low-density lipoprotein levels. Glioblastoma Multiforme (GBM) is the most common, rapidly progressing, and fatal primary brain tumor. It accounts for more than 51% of all gliomas. For this reason, much scientific research is being done to treat brain tumors. This study aims to prepare daidzein-loaded PLGA and PLGA-Gelucire® 44/14 nanoparticles for the treatment of GBM and to evaluate their characteristics, neurotoxicity, and cytotoxicity in vitro. The PLGA and PLGA-Gelucire® 44/14 nanoparticles were prepared by using the non-modified and modified emulsion-solvent diffusion method. The surface morphology, particle size, zeta potential (ZP), encapsulation efficiency (EE) and in vitro release characteristics of nanoparticles were investigated. Furthermore, FT-IR, DSC and SEM were used to characterize these systems. The neurotoxicity on neurons and cytotoxicity against the U-87 MG cell line of the chosen optimum nanoparticle formulations were evaluated. The mean particle size and ZP values of all prepared nanoparticles were a range of 198.52±7.04-672.78±70.95 nm (p≥0.05) and -14.70±0.36--0.50±0.34 mV (p≥0.05), respectively. SEM images of nanoparticles revealed their approximately spherical shape. The EE % values of nanoparticles were a range of % 35.79±3.43-84.85±2.20 (p≥0.05). The cumulative daidzein release from daidzein-loaded nanoparticle formulations was up to about 100 % at 19-37 days of release. It was found that the prepared nanoparticulate systems reduced the neurotoxic effects of daidzein and showed similar cytotoxic effects to those of daidzein (p0.05). The prepared nanoparticles are useful and promising systems for sustained release of daidzein, reduction of the neurotoxic effects of daidzein at high doses (200 μM and 300 μM) and maintaining of its cytotoxic activity against cancer cells.

Daidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal delivery

The Comparison of Different Daidzein-Plga Nanoparticles in Increasing Its Oral Bioavailability

[Preparation and in vitro property evaluation of β-cyclodextrin-daidzein/PEG_(20000)/Carbomer_(940) nanocrystals]

Analysis of Daidzein in Nanoparticles after Oral Co-Administration with Sodium Caprate to Rats by Ultra-Performance Liquid Chromatography–quadrupole-Time-of-flight Mass Spectrometry

Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies.

Tadalafil-loaded nanostructured lipid carriers using permeation enhancers

Preparation and In Vitro Evaluation of Daidzein-Loaded Nanoparticulate Systems

Capsaicin-loaded Nanolipoidal Carriers for Topical Application: Design, Characterization, and in Vitro/in Vivo Evaluation

Preparation of astaxanthin/zeaxanthin-loaded nanostructured lipid carriers for enhanced bioavailability: Characterization-, stability-and permeability study

Mucin Coated Protein-Polyphenol Microcarriers for Daidzein Delivery

Lipid Nanoparticles Loading Triptolide for Transdermal Delivery: Mechanisms of Penetration Enhancement and Transport Properties.

Lipid-based nanoformulation optimization for achieving cutaneous targeting: Niosomes as the potential candidates to fulfill this aim

Optimized preparation of daidzein-loaded chitosan microspheres and in vivo evaluation after intramuscular injection in rats.

Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil

Transdermal Delivery of Lidocaine-Loaded Elastic Nano-Liposomes with Microneedle Array Pretreatment

Challenges in Coopted Hydrophilic and Lipophilic Herbal Bioactives in the Same Nanostructured Carriers for Effective Bioavailability and Anti-Inflammatory Action

Preformulation and characterization of raloxifene-loaded lipid nanoparticles for transdermal administration

Diethylene glycol monoethyl ether-mediated nanostructured lipid carriers enhance trans -ferulic acid delivery by Caco-2 cells superior to solid lipid nanoparticles

Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation

Preparation and in vitro and in vivo Study of Asiaticoside-Loaded Nanoemulsions and Nanoemulsions-Based Gels for Transdermal Delivery

Study on the Inhibitory Effects of Naringenin-Loaded Nanostructured Lipid Carriers Against Nonalcoholic Fatty Liver Disease.